Peer-reviewed research shows CancerIQ more than doubles genetic testing uptake
To identify more effective models for cancer genetic testing, a team of researchers from Boston University School of Public Health, CancerIQ, and University of Washington School of Public Health analyzed patient uptake of genetic counseling and testing after conducting digital cancer risk assessment with CancerIQ.
"Clinical workflows that combine point-of-care genetic testing with CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, more than double the average uptake of genetic testing for hereditary cancer syndromes."
— Healthcare Innovation
